India's Glenmark Sanctioned for Destroying Year's Worth of Documents

Jul 09, 2010

A month after Abbott and Sanofi-Aventis lost a bid to prevent India's Glenmark Pharma from producing a generic version of the blood-pressure medication Tarka, a New Jersey judge has ruled that Glenmark had destroyed key documents that could have altered the outcome of the initial bid. The American Lawyer reports.

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments